Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus

Acta Diabetologica

Volumn 50, Issue 2, 2013, Pages 201-208

  López Tinoco, Cristina ^a   Roca, Mar ^b   García Valero, Amor ^a   Murri, Mora ^b   Tinahones, Francisco J ^b   Segundo, Carmen ^a   Bartha, José L ^a   Aguilar Diosdado, Manuel ^a,c  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Puerta del Mar Hospital   (Spain)

Author keywords

Gestational diabetes mellitus; Markers of oxidative stress; Pregnancy

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; BODY MASS; CESAREAN SECTION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MACROSOMIA; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTIOXIDANTS; CATALASE; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; LIPID PEROXIDES; LOGISTIC MODELS; OXIDATIVE STRESS; PREGNANCY; SUPEROXIDE DISMUTASE;

EID: 84880924755     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0264-2     Document Type: Conference Paper

References (39)

1. Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabetic Med 21:103-113
2. Ostlund I, Hanson U, Björklund A et al (2003) Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 26:2107-2111
3. Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199-1205
4. Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 180:903-916
5. Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568-573
6. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848-854
7. Metzger BE, The Organizing Committee (1991) Summary and recommendations of the 3rd international workshop-conference on gestational diabetes mellitus. Diabetes Care 40(Supp 2):197-201
8. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42-47
9. Bo S, Menato G, Gallo ML, Bardelli C et al (2004) Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 83:335-340
10. Bartha JL, González-Bugatto F, Fernández-Macías R, González-González NL, Comino-Delgado R, Hervías-Vivancos B (2008) Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 137:178-184
11. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
12. Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL (2001) Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 50:404-410
13. Chen K, Thomas SR, Keaney JF (2003) Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 35:117-132
14. Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-823
15. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
16. Haddad JJ (2002) Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 14:799-810
17. Barnes PJ, Karin M (1997) Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
18. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348
19. Santilli F, Cipollone F, Mezzetti A, Chiarelli F (2004) The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 36:319-335
20. Basta G, Schmidt AM, DeCaterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582-592
21. Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072
22. Marfella R, Esposito K, Giunta R et al (2000) Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101:2247-2251
23. Ceriello A, Quagliaro L, Piconi L et al (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701-710
24. Januszewski AS, Alderson NL, Metz TO, Thorpe SR, Baynes JW (2003) Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 31:1413-1416
25. Jenkins AJ, Best JD, Klein RL, Lyons TJ (2004) Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab Res Rev 20:349-368
26. Baynes JW, Thrope SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1-9
27. Viana M, Herrera E, Bonet B (1996) Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 39:1041-1046
28. Peuchant E, Brun JL, Rigalleau V et al (2004) Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 37:293-298
29. Chaudhari L, Tandon OP, Vaney N, Agarwal N (2003) Lipid peroxidation and antioxidant enzymes in gestational diabetics. Indian J Physiol Pharmacol 47:441-446
30. Rajdl D, Racek J, Steinerova A, Novotny Z, Stozicky F, Trefil L (2005) Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res 54:429-436
31. Orhan H, Önderoglu L, Yücel A, Sahin G (2003) Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267:189-195
32. Toescu V, Nuttall SL, Martin U (2004) Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 106:93-98
33. Karacay Ö, Sepici-Dincel A, Karcaaltincaba D et al (2010) A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract 89:231-238
34. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
35. Solomon CG, Willett WC, Carey VJ et al (1997) A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078-1083
36. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E (1992) Longitudinal study of plasma lipoprotein and hormones during pregnancy in normal and diabetic women. Diabetes 41:1651-1659
37. Koukko E, Watts GF, Lowy C (1996) Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 49:634-637
38. American Diabetes Association (1996) Gestational diabetes mellitus. Diabetes Care 27:88-90
39. Herranz L, Villaroel A, Riesco G et al (2003) Elective delivery in women with gestational diabetes mellitus. Diabetología 46:A248-A249